Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.38 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.37 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24871287 | 0.83 | KCNH2 (0.44) | TSHRESR1ESR2KCNH2TP53 | |
| SCHEMBL13319903 | 0.82 | TSHR (0.44) | TSHRESR1ESR2KCNH2TP53 | |
| SCHEMBL25587208 | 0.82 | TSHR (0.44) | TSHRESR1ESR2KCNH2TP53 | |
| SCHEMBL18482012 | 0.80 | IDO1 (0.41) | TSHRESR1BCHEACHEMAPT | |
| SCHEMBL31058637 | 0.80 | ALDH1A1 (0.44) | TSHRESR1ALDH1A1MAPT | |
| SCHEMBL18471310 | 0.79 | MITF (0.38) | TSHRKCNH2TP53BCHEACHE | |
| SCHEMBL22477583 | 0.77 | KIF11 (0.47) | TSHRESR1ESR2KCNH2TP53 | |
| SCHEMBL23512925 | 0.77 | ESR1 (0.48) | TSHRESR1ESR2KCNH2TP53 | |
| SCHEMBL19454941 | 0.77 | ESR1 (0.58) | TSHRESR1ESR2KCNH2TP53 | |
| SCHEMBL24700086 | 0.76 | ACHE (0.42) | BCHEACHELMNAMAPTSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4234524-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | Duk San Neolux Co., Ltd. (KR) | 2023-08-30 | — | — | EP | disclosed |
| EP-4219436-A2 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | Duk San Neolux Co., Ltd. (KR) | 2023-08-02 | — | — | EP | disclosed |
| US-11018309-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-05-25 | — | — | US | disclosed |
| US-20170040552-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-02-09 | — | — | US | disclosed |
| US-20170040552-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170040552-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, OSBP | TSHR 3971/4885ESR1 190/4885ESR2 387/4885 |
| US-11018309-B2 | Organic electroluminescent materials and devices | LEF1, OCIAD1, OCIAD2 | TSHR 1282/4885ESR1 145/4885ESR2 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.